People with AIDS also have HIV, as HIV is the first stage of AIDS. Learn about the differences, how the conditions overlap, ...

The Colorado Department of Public Health and Environment projected that new HIV diagnoses will total 482 in 2024 — virtually ...

New research shows how a specially trained population of immune cells keeps the peace by preventing other immune cells from attacking their own. The study provides a better understanding of immune ...

A research team led by Mount Sinai has uncovered mechanisms of abnormal immune cell function that may lead to Crohn's disease ...

A study has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer ...

A research team led by Prof. Liu Xuanyong from the Shanghai Institute of Ceramics of the Chinese Academy of Sciences has ...

One dose of the Jynneos vaccine was 58% effective against mpox infection overall and 84% in people without HIV, but only 35% ...

Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against mpox with 84% ...

Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% ...

Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.

Discover why starting HIV treatment promptly preserves immune function, prevents transmission, improves quality of life and reduces costs ...

Yearly lenacapavir injection for HIV prevention shows safety and long-lasting effects, according to clinical trial results.